Informational only · Not medical advice

Treatments · Mind and gut

Mindfulness and meditation

What ACG 2021, BSG 2021 and NICE say about mindfulness and meditation for IBS, with the studies, trials, news, and stories we have tagged to it.

Updated on
Written by
TreatIBS Editorial

What the guidelines say

BodyPositionStrength and evidenceSource
ACG 2021Suggests that gut-directed psychotherapies be used to treat global IBS symptoms; the guideline's abstract does not name mindfulness-based programmes specifically.Conditional recommendationVery low quality of evidencePubMed
BSG 2021Recommends IBS-specific cognitive behavioural therapy and gut-directed hypnotherapy as psychological therapies for global symptoms; mindfulness-based programmes are not addressed.Strong recommendation (for CBT and hypnotherapy)Low quality of evidencePubMed
NICEAdvises healthcare professionals to encourage people with IBS to identify and make the most of their available leisure time and to create relaxation time; referral for psychological interventions is considered for refractory IBS, with mindfulness not named.Not gradedSource
On this page
  1. Studies
  2. Trials

Mindfulness training teaches intentional attention to present-moment experience and non-judgmental awareness of body sensations and emotions, usually through an eight-week group programme such as mindfulness-based stress reduction (MBSR) with weekly sessions, a half-day retreat, and daily home practice PMID 21691341. In IBS the proposed mechanism is not relaxation as such but a change in how gut sensations are noticed and interpreted, reducing the catastrophising and vigilance that amplify pain. It sits alongside CBT and hypnotherapy as a brain-gut behavioural approach, though with a smaller trial base.

The best-designed trial randomised 75 women with IBS in North Carolina to eight weekly sessions plus a half-day intensive of either mindfulness training or a support group with the same contact time. IBS severity fell by 26.4% in the mindfulness group versus 6.2% in the support group immediately after training, and by 38.2% versus 11.8% at three-month follow-up; quality of life, psychological distress, and visceral anxiety did not differ between groups right after treatment but did at three months. Participants rated the two programmes as equally credible after the first session, which argues against expectation alone explaining the result PMID 21691341. A Canadian trial randomised 90 patients to an immediate MBSR programme or a wait list; symptom severity improved more with MBSR after the course, but dropout was 44% in the MBSR arm versus 23% in controls, and at six months the wait-list group had also improved so that the between-group difference was no longer statistically significant PMID 22618308.

A later single-arm study at UCLA followed 68 adults through an eight-week MBSR class without a control group and reported a 71% responder rate for gastrointestinal symptoms, with increases in the “acting with awareness” facet of mindfulness most strongly predicting improvement PMID 32266762. Uncontrolled results like this show that the programme is feasible and point to mechanisms, but cannot separate the training from time, attention, and regression to the mean. The 2020 network meta-analysis of 41 psychological-therapy trials in IBS found the largest and most consistent evidence for CBT and gut-directed hypnotherapy, and warned that risk of bias was high across the field and that effects were probably overestimated PMID 32276950.

Points clinicians commonly raise: the two randomised trials used different controls and got different durability, so the honest summary is “promising, not settled”; an active control such as a support group is a harder test than a wait list, and the mindfulness result survived it at least to three months; eight weeks of group sessions plus daily practice is a real commitment, and dropout in one trial was high; and mindfulness apps and short courses have not been tested in IBS, so results from structured MBSR should not be assumed to apply to them.

Talk to a clinician before starting or stopping anything.

References

  1. 1Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021. PMID 33315591
  2. 2Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021. PMID 33903147

TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.

Studies

Recent PubMed entries tagged to Mindfulness.

All research

Trials

Registered interventional studies tagged to this approach.

All trials

News

Headlines that mention this approach, linked to the original.

All news

No news items mention Mindfulness yet.

Stories

Public accounts from people who tried it, labeled as individual experience.

All stories

No stories about Mindfulness yet.

Critiques

Single-study critiques that cover this approach.

All critiques

No critiques on Mindfulness yet.